BTAI
Bioxcel Therapeutics
$0.87
+$0.02 (+2.24%)Jul 27, 2026
Key metrics
The numbers that frame BTAI today
- Market cap
- $26.77M
- P/E (TTM)
- -0.4
- EV / FCF
- -1.9
- Gross margin
- 36.3%
- EV / Sales
- 161.6
- ROIC
- -78.8%
- Div yield
- 0%
- 52wk Low
- $0.74
- 52wk High
- $8.08
Growth
Revenue and earnings trend for BTAI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BTAI
Is Bioxcel Therapeutics a good buy?
No. Bioxcel Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Bioxcel Therapeutics is selling at a very high price.
What is the market capitalization of BTAI?
Bioxcel Therapeutics's market capitalization is $26.77M.
What is the P/E ratio for BTAI stock?
Bioxcel Therapeutics's current P/E ratio is -0.4.
What is the 52-week high for BTAI stock?
The 52-week high for Bioxcel Therapeutics is $8.08. The current close of $0.87 is 89.3% below that high.
What is the 52-week low for BTAI stock?
The 52-week low for Bioxcel Therapeutics is $0.74. The current close of $0.87 is 17.6% above that low.
Does BTAI stock pay dividends?
Bioxcel Therapeutics does not currently show a dividend per share in the company data.